Agency for Healthcare Research and Quality (AHRQ)

Disclosures

March 01, 2012

In This Article

Comparison of Recommendations: Homocysteine Level

ACCF/AHA (2010)

No recommendations provided.

NACB (2009)

Currently homocysteine is regarded as a modest independent CVD risk factor and homocysteine screening for primary prevention and assessment of CVD risk in healthy individuals is not warranted.

USPSTF (2009)

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of using the nontraditional risk factors discussed in this statement* to screen asymptomatic men and women with no history of CHD to prevent CHD events. This is an I statement.

*hs-CRP, ABI, leukocyte count, fasting blood glucose level, periodontal disease, carotid IMT, CAC score on EBCT, homocysteine level, and lipoprotein(a) level

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....